Sign in
4

Changes in Ownership

PHIBRO ANIMAL HEALTH CORP Filed Acc 0001104659-26-013378

Chief Financial Officer disposed of 12,528 shares (other)

  • Chief Financial Officer acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

David Glenn · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-02-09 Exercise or conversion : show line 1 in the form +30,000 64,845 D
2026-02-11 Other disposition : show line 2 in the form −12,528 $51.63 $646,758 52,317 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-02-09 Exercise or conversion : show line 3 in the form Restricted Stock Units −30,000 240,000 D
Loading xslF345X05/tm265965-2_4seq1.xml…